US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...
The allocation of N35.75 billion for capital expenditure in the 2025 Appropriation Bill to the Ministry of Marine and Blue Econom ...
Agronomics (ANIC), a leading alternative proteins company with a focus on cellular agriculture and cultivated meat, has ...
North Carolina life sciences companies, startups and academic institutions are tackling some of the world's greatest ...
Senator Doug Mastriano announced he plans to introduce the “Food Purity Protection Act” in Pennsylvania to prevent vaccines ...
NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is headquartered in Santa Ana, ...
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...
Cambridge-based biopharmaceutical company Sage Therapeutics filed a lawsuit against their partner, the biotechnology company ...
David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback